Mutations in the KRAS gene are present in 90% of PDAC [25], TP53 mutations occur in ∼75% of PDAC [26], and 55% of pancreatic tumors have SMAD4/DPC4 deletions or mutations [27]. Here, KRAS is linked to pancreatic neoplasm.